Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products...
...This evaluation provides the link between the new combination drug product and the drug.....If one or more of the approved drug components is covered by a patent, the FDA could not.....15 Sponsors should evaluate the stability of the drug product in the actual dispensing package..
http://www.fda.gov/oc/initiatives/hiv/hivguidance.html (score=100)

Guidance for Industry
...link between the new combination drug product and the drug products whose safety, efficacy, 280.....Applicants should consider differences in food instructions between individual components.....or three-drug fixed dose combination or co-packaged product with combined labeling showing..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04D-0228-GDL0001-6283dft.pdf (score=98)

Document
...administering the drug at the wrong manufacture, processing, and packing of components.....manufacturer, product, and package. prevent the introduction, transmission, drug product.....and blood components. bar coding standard for blood and blood components to contain, at a..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04-4249.pdf (score=68)

...A change in the primary packaging components for any drug product when the primary packaging components control[20.....Different reporting categories are recommended once CDER has reviewed certain components/materials in association with a drug product.....This applies to any material where such procedures are necessary, including drug substance, drug product..
http://www.fda.gov/cder/guidance/3516fnl.doc (score=66)

Changes to an Approved NDA or ANDA
...This is applicable to any material where such procedures are necessary, including drug substance, drug product.....A change in the primary packaging components for any product when the primary packaging components control the dose delivered.....A move to a different manufacturing site for the manufacture or processing of any drug product, in-process material, or drug..
http://www.fda.gov/cder/guidance/2766fnl.htm (score=66)

þÿ
...This applies to any material where such procedures are necessary, including drug substance, drug product.....recommended once CDER has reviewed certain components/materials in association with a drug.....identity, strength, quality, purity, or potency of a drug product as these factors may relate..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1999d-0529-gdl0003.pdf (score=66)

þÿ
...This applies to any material where such procedures are necessary, including drug substance, drug product.....recommended once CDER has reviewed certain components/materials in association with a drug.....identity, strength, quality, purity, or potency of a drug product as these factors may relate..
http://www.fda.gov/cder/guidance/3516fnl.pdf (score=66)

MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....recommended for inclusion in the application regarding the components, manufacturing.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=61)

Guidance for Industry
...products shall be excluded from direct contact with components, drug product containers, closures, in.....specifications, standards, sampling plans, and test procedures designed to assure that components, drug.....the acceptance of each lot within each shipment of components, drug product containers, closures, and..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=59)

Document
...Food and Drug Administration, Rockville Pike, suite 200N, Rockville, factual information.....this proposed rule on or before April 18, throughout the lifetime of the product. issuance.....apply to the drug or device components of.. confidential commercial information where such..
http://www.fda.gov/OHRMS/DOCKETS/98fr/011801b.pdf (score=58)

FR 9/30/97 Natural Rubber-Containing Medical Devices; User Labeling
...Combination products that have device and drug components but are regulated under drug.....The Packaging of This Product Contains Natural Rubber Latex Which May Cause Allergic.....The agency believes, however, that this requirement will not affect many drug vial containers, because most drug stoppers are..
http://www.fda.gov/cdrh/dsma/fr93097.html (score=57)

...Device manufacturers must assure that manufacturing steps do not adversely affect drug.....If the labeling of the drug and device create a combination product, as defined in the combination product regulations, then.....Device incorporating a drug component with the combination product having the primary intended purpose of fulfilling a device..
http://www.fda.gov/oc/ombudsman/drug-dev.htm (score=57)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....evaluation can include testing of the material (see Section VI, Control of Components, 276.....or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=20)

þÿ
...the methods, facilities, and controls it needs to ensure product quality. Instead.....an inactive ingredient a product that is marketed as a finished drug product intended.. for intravenous administration, the PET.....components, and conducted at least a visual identification of each lot of containers or..
http://www.fda.gov/cder/regulatory/pet/changestoprelimdraftregs-summary.PDF (score=219)

FDA’s Response to Issues Raised by the PET Community Regarding the 1999...
...If the PET center uses as an inactive ingredient a product that is marketed as a finished drug product intended for intravenous.....Rather than having to conduct an identity test on each lot of all components, a PET center.....The PET community stated that it would like to be able to release a PET drug product when a PET..
http://www.fda.gov/cder/regulatory/pet/responseToDraftReg.htm (score=179)

GUIDE TO INSPECTIONS OF DOSAGE FORM DRUG MANUFACTURER'S - CGMPR'S
...Determine the validity, and accuracy of the firm's inventory system for drug components.....Components or finished product adulterated by rodents, insects, or chemicals must be documented and submitted for.....If the product is an OTC drug which is covered by an NDA or ANDA, FDA may review, copy and verify the..
http://www.fda.gov/ora/inspect_ref/igs/dose.html (score=100)

Sterile Drug Products Produced by Aseptic Processing
...Drug product components, containers, closures, storage time limitations, and manufacturing equipment.....Components and drug product containers and closures shall at all times be handled and stored in a manner to.....Drug product containers and closures shall be clean and, where indicated by the nature of the..
http://www.fda.gov/cder/guidance/5882fnl.htm (score=59)

Guidance for Industry
...products shall be excluded from direct contact with components, drug product containers, closures, in.....specifications, standards, sampling plans, and test procedures designed to assure that components, drug.....the acceptance of each lot within each shipment of components, drug product containers, closures, and..
http://www.fda.gov/cder/guidance/1874dft.pdf (score=59)

...One comment also argued that FDA already has names and addresses of agents for each product as part of a drug.....drug components that are imported into the United States for further processing or.....the license holder of the final product versus the establishment owner of the bulk drug..
http://www.fda.gov/OHRMS/DOCKETS/98fr/112701a.htm (score=58)

I.S.P. Company, Inc Warning Letter
...Failure to test each lot of incoming drug components, containers, and finished product to.....The active ingredient, iodine, is not included in the final rule for topical antifungal.....drug product and to maintain a system by which the distribution of each lot of drug product can..
http://www.fda.gov/foi/warning_letters/g4745d.htm (score=58)

Las Vegas Injury Lawyer